Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 4, 2001

View Archived Issues

Cephalon reports changes in Gabitril product name

Physiome Sciences licenses PathwayPrism technology to 3rd Millennium

Samaritan's Anticort completes phase Ib/IIa clinical trial for HIV infection

Study investigates Toprol-XL for reversal of cardiac remodeling

AtheroGenics files IND for intravenous AGIX-4207 to treat RA

Senju to develop ocular formulation of betotastine

Modex reports positive preliminary results from EpiDex phase II clinical trial

Levulan progress reported by Dusa during Q2

Hybrid molecule enhances insulin secretion and reduces insulin resistance

Dose-finding trial results presented this week for new fibrin-specific thrombolytic agent

Improvement in ischemic limb muscle oxygenation reported for 5-HT2A receptor antagonist

Beneficial effects of HMR-1098 in atrial and ventricular fibrillation

Effects of rPSGL-Ig in canine model of myocardial ischemia-reperfusion injury

AIDS therapeutic from Takeda enters clinical testing

Metabasis receives SBIR grant for hepatitis B prodrug development

Structure, pharmacological profile of new bladder-selective K(ATP) channel openers presented at ACS

Histone deacetylase inhibition as a novel therapeutic approach to atherosclerosis and restenosis

AstraZeneca reassesses ZD-0473 phase III clinical program in ovarian cancer

Rational design of antimalarial trioxane with promising preclinical efficacy/toxicity profile

BMS files IND for obesity drug candidate developed with Karo Bio

Feridex I.V. sNDA deemed not approvable by FDA

Pyrazolopyridine adenosine A1 antagonist selected for further development at Fujisawa

Macrolides discovered at Pfizer with antiinfective and prokinetic properties

New compounds with estrogenic or antiestrogenic effects claimed by Pfizer

Antiallergic/antiinflammatory agents from Ube act as leukotriene antagonists

Immunomodulatory peptides identified by Entopharm

Amycomycin: a new antibiotic produced by Amycolatopsis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...